The supermodel also provided a raw and personal look into the medical issues that forced her into "hibernation" for five ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

The discovery offers insight into why shift workers experience metabolic disruption, which could lead to new therapies for ...

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and ...

Researchers from Adipo Therapeutics LLC presented data from preclinical studies that aimed to assess the γ-secretase inhibitor ADPO-002 (dibenzazepine) for the treatment of obesity.

Regenerative medicine is rapidly developing and is already being applied in most countries worldwide. However, the best ...

Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective ...

This study demonstrates that global or adipose tissue-specific knockout of CIDEC/FSP27 significantly reduces AAA incidence ...

This is how long the peace negotiation between the Government of India and the NSCN (IM) has dragged on. A child born back then would now be 27 years old and a strapping young man or woman of 27 back ...

The increases in PGC1⍺, PRDM16 and Uncoupling Protein 1 (UCP1) in these studies support ADPO-002's mechanism of action for mitochondrial biogenesis, activation and browning of human white adipose ...

Recent research reveals that the immune system interacts with the body's internal clock, influencing both fat storage and ...